RhoBTB2 is a substrate of the mammalian Cul3 ubiquitin ligase complex

Genes and Development

Volumn 18, Issue 8, 2004, Pages 856-861

  Wilkins, Andrew ^a   Ping, Qinggong ^a   Carpenter, Christopher L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cancer; Cullin; DBC2; Rho; Ubiquitin

Indexed keywords

RHO GUANINE NUCLEOTIDE BINDING PROTEIN; UBIQUITIN PROTEIN LIGASE CUL3; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CHROMOSOME 8P; CONTROLLED STUDY; ENZYME SUBSTRATE; GENE DELETION; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG CANCER; MISSENSE MUTATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RHOBTB2 GENE; TUMOR SUPPRESSOR GENE;

ANIMALS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MICE; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RHO GTP-BINDING PROTEINS; TWO-HYBRID SYSTEM TECHNIQUES; UBIQUITIN-PROTEIN LIGASES;

MAMMALIA;

EID: 1942434716     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.1177904     Document Type: Article

References (23)

1. Brown, M.R., Chuaqui, R., Vocke, C.D., Berchuck, A., Middleton, L.P., Emmert-Buck, M.R., and Kohn, E.C. 1999. Allelic loss on chromosome arm 8p: Analysis of sporadic epithelial ovarian tumors. Gynecol. Oncol. 74: 98-102.
2. Collins, T., Stone, J.R., and Williams, A.J. 2001. All in the family: The BTB/POZ, KRAB, and SCAN domains. Mol. Cell. Biol. 21: 3609-3615.
3. Deshaies, R.J. 1999. SCF and Cullin/Ring H2-based ubiquitin ligases. Annu. Rev. Cell Dev. Biol. 15: 435-467.
4. Devroe, E. and Silver, P.A. 2002. Retrovirus-delivered siRNA. BMC Biotechnol. 2: 15.
5. Furukawa, M., He, Y.J., Borchers, C., and Xiong, Y. 2003. Targeting of protein ubiquitination by BTB-Cullin 3-Roc1 ubiquitin ligases. Nat. Cell Biol. 5: 1001-1007.
6. Geyer, R., Wee, S., Anderson, S., Yates, J., and Wolf, D.A. 2003. BTB/ POZ domain proteins are putative substrate adaptors for cullin 3 ubiquitin ligases. Mol. Cell 12: 783-790.
7. Groisman, R., Polanowska, J., Kuraoka, I., Sawada, J., Saijo, M., Drapkin, R., Kisselev, A.F., Tanaka, K., and Nakatani, Y. 2003. The ubiquitin ligase activity in the DDB2 and CSA complexes is differentially regulated by the COP9 signalosome in response to DNA damage. Cell 113: 357-367.
8. Hamaguchi, M., Meth, J.L., von Klitzing, C., Wei, W., Esposito, D., Rodgers, L., Walsh, T., Welcsh, P., King, M.C., and Wigler, M.H. 2002. DBC2, a candidate for a tumor suppressor gene involved in breast cancer. Proc. Natl. Acad. Sci. 99: 13647-13652.
9. James, P., Halladay, J., and Craig, E.A. 1996. Genomic libraries and a host strain designed for highly efficient two-hybrid selection in yeast. Genetics 144: 1425-1436.
10. Jin, J., Shirogane, T., Xu, L., Nalepa, G., Qin, J., Elledge, S.J., and Harper, J.W. 2003. SCFβ-TRCP links Chk1 signaling to degradation of the Cdc25A protein phosphatase. Genes & Dev. 17: 3062-3074.
11. Lisztwan, J., Imbert, G., Wirbelauer, C., Gstaiger, M., and Krek, W. 1999. The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitin-protein ligase activity. Genes & Dev. 13: 1822-1833.
12. Maxwell, P.H., Wiesener, M.S., Chang, G.W., Clifford, S.C., Vaux, E.C., Cockman, M.E., Wykoff, C.C., Pugh, C.W., Maher, E.R., and Ratcliffe, P.J. 1999. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399: 271-275.
13. Ohh, M., Park, C.W., Ivan, M., Hoffman, M.A., Kim, T.Y., Huang, L.E., Pavletich, N., Chau, V., and Kaelin, W.G. 2000. Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel-Lindau protein. Nat. Cell Biol. 2: 423-427.
14. Pause, A., Lee, S., Worrell, R.A., Chen, D.Y., Burgess, W.H., Linehan, W.M., and Klausner, R.D. 1997. The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins. Proc. Natl. Acad. Sci. 94: 2156-2161.
15. Pickart, C.M. 2001. Mechanisms underlying ubiquitination. Annu. Rev. Biochem. 70: 503-533.
16. Pintard, L., Willis, J.H., Willems, A., Johnson, J.L., Srayko, M., Kurz, T., Glaser, S., Mains, P.E., Tyers, M., Bowerman, B., et al. 2003. The BTB protein MEL-26 is a substrate-specific adaptor of the CUL-3 ubiquitin-ligase. Nature 425: 311-316.
17. Ramos, S., Khademi, F., Somesh, B.P., and Rivero, F. 2002. Genomic organization and expression profile of the small GTPases of the RhoBTB family in human and mouse. Gene 298: 147-157.
18. Schulman, B.A., Carrano, A.C., Jeffrey, P.D., Bowen, Z., Kinnucan, E.R., Finnin, M.S., Elledge, S.J., Harper, J.W., Pagano, M., and Pavletich, N.P. 2000. Insights into SCF ubiquitin ligases from the structure of the Skp1-Skp2 complex. Nature 408: 381-386.
19. Vojtek, A.B., Hollenberg, S.M., and Cooper, J.A. 1993. Mammalian Ras interacts directly with the serine/threonine kinase Raf. Cell 74: 205-214.
20. Wistuba, I.I., Behrens, C., Virmani, A.K., Milchgrub, S., Syed, S., Lam, S., Mackay, B., Minna, J.D., and Gazdar, A.F. 1999. Allelic losses at chromosome 8p21-23 are early and frequent events in the pathogenesis of lung cancer. Cancer Res. 59: 1973-1979.
21. Xu, L., Wei, Y., Reboul, J., Vaglio, P., Shin, T.H., Vidal, M., Elledge, S.J., and Harper, J.W. 2003. BTB proteins are substrate-specific adaptors in an SCF-like modular ubiquitin ligase containing CUL-3. Nature 425: 316-321.
22. Zheng, N., Schulman, B.A., Song, L., Miller, J.J., Jeffrey, P.D., Wang, P., Chu, C., Koepp, D.M., Elledge, S.J., Pagano, M., et al. 2002. Structure of the Cul1-Rbx1-Skp1-F boxSkp2 SCF ubiquitin ligase complex. Nature 416: 703-709.
23. Zhou, P. and Howley, P.M. 1998. Ubiquitination and degradation of the substrate recognition subunits of SCF ubiquitin-protein ligases. Mol. Cell 2: 571-580.